U.S. Markets close in 5 hrs, 15 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,416.48 | -34.47 | -0.33% |
| NASDAQ | 2,164.85 | -11.16 | -0.51% |
| S&P 500 | 1,103.81 | -2.43 | -0.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 16.71 10:19 AM EST | |
|---|---|---|
| Day High | 17.05 09:40 AM EST |
|
| Range | 0.34 |
| Volume | 139,757 | |
|---|---|---|
| 30-Day Avg Vol | 973,000 |
|
| Difference | -85.64% |
| Market Cap | 970.03 M | |
|---|---|---|
| Mkt Cap Chg | -14.48 M |
| Shares Out | 57.94 M | |
|---|---|---|
| % Shrs Traded | 0.24% | |
| 1yr EPS Est | 1.41 |
| 52-Wk Low | 13.81 | |
|---|---|---|
| 52-Wk High | 28.74 |
|
| Range | 14.93 |
| Prev Close | 16.99 11/23/09 | |
|---|---|---|
| Today's Open | 16.96 | |
| Change | -0.18% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.47 M |
| Revenue (LFY) | 433.64 M | |
|---|---|---|
| Earnings (LFY) | 169.82 M | |
| Earnings (MRQ) | 25.38 M | |
| Next Earn Est | 0.409 | |
| Next Earnings | 01/18/2010 |
|
| EPS (TTM) | 2.80 | |
| 1yr EPS Growth | -49.10% |
| P/E Ratio (TTM) | 5.66 | |
|---|---|---|
| P/E Ratio (Fwd) | 11.00 | |
| PEG Ratio | 0.51 | |
| Return on Equity | 73.19 | |
| Beta | 0.69 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Fighting infection is a modern art form at Cubist Pharmaceuticals. The company is developing antimicrobial agents that aim to treat drug-resistant infections typically found in hospitals and other health ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.409 1/18/10 | — — |
—
—
|
| Last Quarter | 0.328 9/30/09 | 0.42 9/30/09 |
0.092
Beat
|
| 2 Quarters Ago | 0.278 6/30/09 | 0.40 6/30/09 |
0.122
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 143.53 M | 433.64 M |
| Gross Profit | 112.76 M | 343.26 M |
| Operating Income | 45.50 M | 93.19 M |
| Net Income | 25.38 M | 169.82 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts